Molecular structure of Haloperidol, CAS Number: 52-86-8
Haloperidol (CAS 52-86-8)
Alternate Names:
4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone, 4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4′-fluorobutyrophenone, 4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4′-fluorobutyrophenone
CAS Number:
52-86-8
Molecular Weight:
375.86
Molecular Formula:
C21H23ClFNO2
Supplemental Information:
This is as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Haloperidol (CAS 52-86-8) References
- Depot haloperidol decanoate for schizophrenia. | Quraishi, S. and David, A. 2000. Cochrane Database Syst Rev. 1999: CD001361. PMID: 10796438
- Intravenous haloperidol for tranquilization in critical care patients: a review and critique. | Ziehm, SR. 1991. AACN Clin Issues Crit Care Nurs. 2: 765-77. PMID: 1954061
- [The neurotoxicity of pyridinium metabolites of haloperidol]. | Górska, A., et al. 2015. Postepy Hig Med Dosw (Online). 69: 1169-75. PMID: 26561842
- Pharmacokinetics of haloperidol. | Froemming, JS., et al. 1989. Clin Pharmacokinet. 17: 396-423. PMID: 2689040
- Possible biomarkers modulating haloperidol efficacy and/or tolerability. | Porcelli, S., et al. 2016. Pharmacogenomics. 17: 507-29. PMID: 27023437
- Haloperidol decanoate: a depot antipsychotic. | Hemstrom, CA., et al. 1988. Drug Intell Clin Pharm. 22: 290-5. PMID: 2897276
- Haloperidol Interactions with the dop-3 Receptor in Caenorhabditis elegans. | Krum, BN., et al. 2021. Mol Neurobiol. 58: 304-316. PMID: 32935232
- Haloperidol decanoate. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in psychosis. | Beresford, R. and Ward, A. 1987. Drugs. 33: 31-49. PMID: 3545764
- Haloperidol plasma level monitoring in neuropsychiatric patients. | Morselli, PL., et al. 1982. Ther Drug Monit. 4: 51-8. PMID: 7041338
- Monitoring of serum haloperidol. | Lawson, GM. 1994. Mayo Clin Proc. 69: 189-90. PMID: 8309272
Inhibitor of:
A530099J19Rik, C16orf73, CCDC40, Cerebellin 1, CLPTM1L, Collapsin Response Mediator Protein (CRMP), CRY2, CYP2D10, CYP2D22, CYP2D26, CYP2D34, CYP2D9, D2, D2DR, D5DR, DARPP-32, Dopamine, Dysbindin 1, E230019M04Rik, EG328644, Glrp-1, GPR158, GPR162, GPR171, IGSF9, KCNF1, KCNH4, KCNH7, Kir3, KV6.3, Latrophilin (ADGRL), Latrophilin-1, Latrophilin-2, LEP503, Macoilin, MrgB5, Mtvr2, Muted, NAGS, neurexin III, NK-3R, NPAS3, Olfr1, Olfr10, Olfr1000, Olfr1018, Olfr1030, Olfr1032, Olfr1039, Olfr1056, Olfr1061, Olfr1087, Olfr345, Olfr371, Olfr64, Olfr73, Olfr735, Olfr736, Olfr738, Olfr826, Olfr881, Olfr884, Olfr943, Olr1111, OR1S2, OR2C1, OR2M, OR52E5, OTOP3, PC-PLD2C, Placental lactogen I, PLC 2, PLC-L, PLCδ1, PLP-Cβ, PNMA6A, Regulator of G protein signaling (RGS), RGS16, ROM1, RORβ, SEZ6, Sig-1R, Skint2, SLITRK4, Sln1, SMPDL3A, SNAP 23, sorcin, TAAR6, TAAR7B, TAAR7H, TAAR8C, Tesp2, TH, TMEM117, TMEM97, TMPIT, TSR-1, UNC-79, V1RA1, V1RB5, V1RB7, V1RB8, V1RI2, VMAT 2, Vmn1r101, Vmn1r132, Vmn1r135, Vmn1r142, Vmn1r15, Vmn1r155, Vmn1r17, Vmn1r184, Vmn1r196, Vmn1r30, Vmn1r34, Vmn1r61, Vmn1r86, Vmn1r88, Vmn2r100, Vmn2r107, Vmn2r20, Vmn2r32, Vmn2r34, Vmn2r37, Vmn2r44, Vmn2r48, Vmn2r56, Vmn2r6, Vmn2r67, Vmn2r69, Vmn2r81, VN1R2, and ZNF804A.Activator of:
AGRP, Amylin, D1DR, DISC-1, DRD1a, GPR111, GPR115, GPR52, Homer-1, IMPA2, KCNT1, KIR2.3, Myo-inositol monophosphatase 1, Neuropeptide S, Prolactin, Sig-1R, TASK-2, and xCT.Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Haloperidol, 5 g | sc-507512 | 5 g | $190.00 | |||
| US: (Out of Stock: Availability January 28, 2026) | ||||||